We are a tax consulting and company formation firm located offshore in the sunny, tax free Bahamas since 1990. I've formed over 1,030 Bahamian IBCs and 360 Anguilla IBCs since 1990. ◾Anguilla is a UK overseas territory with same tax status as Cayman Islands. ◾All the money and technology to create their offshore registration services came out of London. ◾Anguilla was one of the very first tax havens that adopted an online registry service. ◾QEII is the head of State. ◾Got questions? email email@example.com The Caribbean tax havens have grown to rival New York and London as a place to hold family assets, and the US FET is one reason why there are so many offshore companies there. 480,000 IBCs in BVI; 100,000 “exempt companies” in Cayman; 45,000 IBCs in the Bahamas; 30,000 cos in Bermuda 25,000 IBCs in Anguilla None of the Caribbean (tax) havens levy an estate tax. https://www.linkedin.com/pulse/federal-estate-tax-chart-below-shows-exemptions-us-citizens-havens Nobody is much interested in tax avoidance any more, so I'm posting Tom's Fishing Gallary pictures instead http://bahamasbahamas.com/images/gallery.html Personal info here https://www.linkedin.com/profile/preview?locale=en_US&trk=prof-0-sb-preview-primary-button and PFIC / FATCA info for planners https://www.linkedin.com/pulse/new-irs-form-8938-created-fatca-2010-can-filing-avoided-tax-havens?trk=prof-post JPMorgan/Chase writes on U.S. Estate taxation: "Because stock of a foreign corporation (in a no tax haven) is not subject to U.S. estate tax, holding U.S. situs assets through a foreign corporation constitutes a planning opportunity." http://www.jpmfinancialservices.com/images/PDFs/EstateTaxation.pdf https://www.linkedin.com/profile/preview?locale=en_US&trk=prof-0-sb-preview-primary-button
TOP 2017 PICKS: $AAPL $150, $TASR $35/$36, $KHC $112.5, $KO $60+
Finance Executive - Consultant - Trader- My directional trades will consist of selling puts and buying call spreads and selling calls and buying put spreads. Selective Employment: United Parcel Service, Canon Latin America, Amazon.com Education 1999 MBA - Wayne Huizenga School of Business at NSU 1995 B.Sc Business Administrative Studies NSU- Banking and Finance Specialty 1992 AA Business Miami Dade Community College 1987-83 Economics Faculdade Candido Mendes RJ Brazil Incomplete Certificates - Series 7 and 63- 2001 Expired - Real Estate sales associate 2004 - Expired Trader for JGM Securities/ Broadway Trading - 2001
Who am I?
Consultant strategist providing competitive and market intelligence to investors in the biopharmaceutical industry ; founder of Qstat Consulting, a boutique strategic consulting firm specialized in competitive markets in Life Sciences industry [http://www.qstatconsulting.com]. In this role, I drive market and competitive intelligence research (primary & secondary) to enable investment strategies and translate findings into critical insights.
What do we offer?
Depending on the requested depth of analysis, we provide primary and secondary research for Key Intelligence Topics (KITs) and Key Intelligence Questions (KIQs).
Under a professional code of conduct, the consultant legally and ethically identify corporate information using a questionnaire technique.
We provide insights and detailed forecast of corporate strategies, which are essential for an investment decision making-process (e.g. the exact release date of trial data, any side-effects, safety or lack of efficacy to be further investigated, go-to-market plans, pricing structure, global regulatory and medical activities)
The secondary framework combines data about the company, drug(s) of interest (summary, patents and generics, regulatory, pre-marketing, preclinical and clinical activities, pricing, market target), marketing research, upcoming milestones, internal strengths and weaknesses, external opportunities and threats, competitive profile matrix (innovation, use of corporate assets, financial soundness, long-term investment, global competitiveness, acquisition, product diversification, product quality, marketing, R&D, patents...)
Primary and secondary data can be combined together to create a full-report, which confidential data are essential in the investment strategy.